Exploring Uptrends: $CI, $HUM, $MOH, $ELV, $OSCR Lead Managed Health Care’s +5.23% Gain!
As the Managed Health Care sector experiences a 5.23% gain, this analysis will spotlight on how specific tickers contributed to this uptrend over the last month. We’ll concentrate on $CI, $HUM, $MOH, $ELV, and $OSCR, diving into their performance and market behavior.
💼 Managed Health Care Sector: Elevate Your Trading Game with AI Robots! 💼
If you're keen on exploring the Managed Health Care group, we have the perfect tools to assist you in your trading journey. 🏥📈
🔄 "Swing Trader for Beginners: Trading in Markets Trending Down (TA&FA)" is designed to help you navigate markets in decline. Whether you're a seasoned trader or just starting, this AI robot can provide valuable insights and strategies to thrive in challenging conditions.
⬆️ On the flip side, "Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA)" is your go-to companion when markets are on the rise. It offers a tailored approach to capitalize on upward trends and maximize your trading potential.
With these AI-powered tools at your disposal, you can confidently trade within the Managed Health Care sector, adapting to different market conditions and making informed decisions. Elevate your trading game and embark on a journey of trading excellence! 📊🚀
Tickers in this Group:
$CI - $HUM - $UNH - $MOH - $CNC - $CVS - $ELV - $OSCR - $ALHC
Description
Managed Health Care firms offer crucial health, medical, and disability plans aiming to streamline the cost of health care services. Major firms in this sector, including Aetna, Humana Inc., Cigna, UnitedHealthcare, provide insurance through various channels, ultimately aiming to make health care more accessible and affordable to the public.
Market Cap Analysis
With a group average market capitalization of $96.3B, the sector presents a diverse range of companies from $UNH at the pinnacle with $473B to $OSCR at $1.2B. This vast difference outlines the sector's diversity, offering traders various options to invest based on their market cap preference.
High and Low Price Notable News
The sector observed an average weekly growth of 0.45%, with a monthly enhancement of 5.77%. $ALHC leads the growth at 8%, while $ELV experienced a 1.53% decline. These fluctuations provide traders with insights into the tickers’ volatility and potential investment return.
Volume Insights
The sector’s stocks recorded an average weekly volume growth of -1.11%, with a significant decrease in the monthly and quarterly volume growth, which traders should consider when planning their investment strategies.
Fundamental Analysis Ratings
- Valuation Rating: 40
- P/E Growth Rating: 73
- Price Growth Rating: 43
- SMR Rating: 78
- Profit Risk Rating: 50
- Seasonality Score: 52
Ticker Spotlight: $CI, $HUM, $MOH, $ELV, $OSCR
$CI - Cigna Group (The)
$CI has shown a promising upward trend with its 10-day moving average crossing above its 50-day counterpart, signaling a potential buying opportunity with an 86% chance of continued growth.
$HUM - Humana
With its price surging above the 50-day moving average, $HUM indicates a strong upward trend, providing traders an 80% likelihood of further price increase in the upcoming month.
$MOH - Molina Healthcare
$MOH broke its lower Bollinger Band, suggesting a potential rise back towards the middle band. With an 81% chance of upward movement, this ticker presents a promising buy for traders.
$ELV - Elevance Health
$ELV is expected to rebound from its lower Bollinger Band, offering traders a probable 78% chance of engaging in a continued uptrend in the next month.
$OSCR - Oscar Health
Breaking its lower Bollinger Band, $OSCR provides traders with a compelling buy option, boasting an 83% probability of sustaining its upward trend.
With the Managed Health Care sector experiencing a +5.23% gain, tickers like $CI, $HUM, $MOH, $ELV, and $OSCR are at the forefront of this positive movement. As traders, understanding the nuances of each ticker’s performance, market cap, and volume growth is crucial for making informed investment decisions in this thriving sector.
CI in +1.19% Uptrend, advancing for three consecutive days on March 28, 2025
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CI advanced for three days, in of 346 cases, the price rose further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on March 26, 2025. You may want to consider a long position or call options on CI as a result. In of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 252 cases where CI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for CI moved out of overbought territory on March 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Moving Average Convergence Divergence Histogram (MACD) for CI turned negative on March 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CI broke above its upper Bollinger Band on March 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.234) is normal, around the industry mean (3.063). P/E Ratio (20.936) is within average values for comparable stocks, (17.509). Projected Growth (PEG Ratio) (0.928) is also within normal values, averaging (1.089). Dividend Yield (0.014) settles around the average of (0.020) among similar stocks. P/S Ratio (0.554) is also within normal values, averaging (0.684).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a provider of life, hospital and medical insurance plans
Industry ManagedHealthCare